Company Filing History:
Years Active: 2022
Title: Innovator Lewis Joe Stafford: Pioneering Cancer Diagnostics and Therapeutics
Introduction
Lewis Joe Stafford, an accomplished inventor based in Rockville, MD, has made significant strides in the field of cancer research. His innovative work focuses on the development of specific antigens and antibodies crucial for diagnosing and treating various cancers, including pancreatic and colon cancer.
Latest Patents
Stafford holds a patent for "Colon and pancreas cancer specific antigens and antibodies." This groundbreaking invention pertains to the NPC-1 antigen found on the MUC5AC protein, the 16C3 antigen on CEACAM5 and CEACAM6 proteins, and the 31.1 epitope on the A33 protein. These entities are differentially expressed in cancers such as lung cancer, ovarian cancer, pancreatic cancer, breast cancer, and colon cancer, opening new avenues for diagnostic and therapeutic applications. His patent details the use of these antigens and their corresponding antibodies in diagnostic and treatment methods.
Career Highlights
Lewis Joe Stafford works at Precision Biologics, Inc., where he continues to advance his research and contribute to the field of oncology. His expertise has enabled him to create innovative solutions aimed at improving cancer diagnosis and therapies, significantly impacting patient care.
Collaborations
Throughout his career, Stafford has collaborated with talented professionals in his field, including Xiulian Du and Janos Luka. These partnerships have fostered a collaborative environment that enhances the development and potential application of his innovative discoveries.
Conclusion
Lewis Joe Stafford represents the forefront of innovation in cancer research, with his patent addressing critical issues related to cancer diagnostics and therapeutics. His ongoing contributions and collaborations continue to make a profound impact in fighting cancer and improving treatment outcomes for patients.